Coral drug

Recent Articles

RELATED ARTICLES

  1. The drug maker boosted sales of its core anti-cancer product in the first half of the year and reined in its research budget under a reform-minded CEO, but revenue momentum lags the pace of leading rivals.
    Junshi narrows its losses but delivers no cure for share price woes
    1877.HK 688180.SHG
  2. Junshi hopes new scientist CEO can cure its woes
    1877.HK 688180.SHG
  3. BeiGene still bleeding red ink despite blockbuster drug
    BGNE.US 6160.HK 688235.SHG
  4. Akeso marks profit milestone with swift rights issue
    9926.HK
  5. Innovent Bio hopes for plus-sized profits from obesity drug
    1801.HK
  6. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva